S2E7: 'Meet the Innovators' - Leonard Weisman, MD, Co-founder, President, and CTO, Vax-Immune Diagnostics

S2E7: 'Meet the Innovators' - Leonard Weisman, MD, Co-founder, President, and CTO, Vax-Immune Diagnostics

LabReady, Set, Go: Accurately Diagnosing Infections Faster and From Home”  Houston medical device diagnostics start-up, Vax-Immune Diagnostics LLC, has developed LabReady, a hand-held, portable, disposable device. This novel diagnostic platform device was designed to revolutionize the identification process of infectious disease. In this interview, co-founder, President, and CTO Leonard Weisman, MD talks about his experiences in co-founding the company and what’s next for Vax-Immune.

'In MedTech History' - The Human Genome

'In MedTech History' - The Human Genome

The year 2003 was historic for a number of reasons: the Iraq War, the loss of the Space Shuttle Columbia and her crew, and the conclusion of the world's largest collaborative biological project: the Human Genome Project. The knowledge gained from this successful 13-year scientific endeavor has since ushered in an emerging era in genomics and precision medicine, making it possible to predict, diagnose, and treat diseases more precisely and personally than ever.

'In MedTech History' - Bariatric Surgery

'In MedTech History' - Bariatric Surgery

Amidst a growing counterculture sparked by the Vietnam War and the US civil rights movement, bariatric surgery as we know it today had its beginnings in 1965 in a research laboratory at the University of Iowa. Today, as obesity reaches epidemic proportions, bariatric surgery has established its place as the most effective treatment for achieving substantial weight loss and improving or even resolving comorbid conditions such as diabetes, hypertension, and sleep apnea, especially in the morbidly obese.

S2E6: 'Meet the Innovators' - Jacob Kriegel, MD, co-founder and CMO, Alleviant Medical

S2E6: 'Meet the Innovators' - Jacob Kriegel, MD, co-founder and CMO, Alleviant Medical

“A Hole in the Heart Alleviates HF Symptoms”  Houston medical device start-up, Alleviant Medical, is developing a novel transcatheter technology that applies left atrial decompression to provide symptomatic relief for congestive heart failure. In this interview, co-founder and CMO Jacob Kriegel, MD talks about his experiences in co-founding the company and what’s next for Alleviant Medical.

'In MedTech History' - Cardiac Ablation

'In MedTech History' - Cardiac Ablation

Atrial fibrillation (AF), the most common type of cardiac arrhythmia, affects millions of people worldwide. Thanks to pioneering work by Melvin Scheinman, MD and others nearly 40 years ago in catheter ablation, the need for open-heart surgery or long-term drug therapy for hundreds of thousands of patients with AF or other serious heart rhythm disturbances has been nearly eliminated.

'In MedTech History' - Mammography

'In MedTech History' - Mammography

From its beginnings more than 100 years ago as a simple radiographic image of mastectomy tissue specimens to its present status as the gold standard method of breast cancer detection, mammography serves a critical role in detecting a disease that one in every eight women will be diagnosed with in her lifetime.

ICYMI: HFpEF an Emerging Opportunity in Structural Heart

 ICYMI: HFpEF an Emerging Opportunity in Structural Heart

Start-ups are developing transcatheter treatments for a type of heart failure that has been increasing in prevalence: heart failure with preserved ejection fraction. HFpEF is a huge potential device market because it appears to develop from an accumulation of damages that come with aging rather than a specific cause like heart attack or valve dysfunction.

S2E5: 'Meet the Innovators' - Mehran Talebinejad, PhD, Co-founder and CEO, NeuroQore Inc.

S2E5: 'Meet the Innovators' - Mehran Talebinejad, PhD, Co-founder and CEO, NeuroQore Inc.

“NeuroQore’s Electromagnetics: A New Way to Treat Depression & Neurobehavioral Disorders” Silicon Valley medical device start-up, NeuroQore Inc., has developed a novel platform technology that it believes can be applied to many neurobehavioral disorders and could provide rapid treatment for major depressive disorder (MDD). The team is striving to put an end to the most devastating of all endings: suicide. In this interview, co-founder and CEO Mehran Talebinejad talks about his experiences in co-founding the company and what’s next for NeuroQore.

'In MedTech History' - Colonoscopy

'In MedTech History' - Colonoscopy

The turbulent late 1960s were marked by Vietnam protests, Woodstock, and man’s first steps on the Moon. It was also the dawn of the era of colonoscopy, one of the most significant tools we have against colorectal cancer—the third most commonly diagnosed cancer and second leading cause of cancer death in the US.

'In MedTech History' - Magnetic Resonance Imaging

'In MedTech History' - Magnetic Resonance Imaging

The year 1977 was momentous not only as the year that the personal computer revolution began, but also as the first time that the world saw whole-body MRI images. Now, this magnetic field and radio wave-based technology is a staple of medical imaging, used to noninvasively diagnose a variety of conditions ranging from torn ligaments to tumors.

S2E4: 'Meet the Innovators' - Sahil Diwan, Co-founder and CEO, SafKan Inc.

S2E4: 'Meet the Innovators' - Sahil Diwan, Co-founder and CEO, SafKan Inc.

“OtoSet: Sonicare for the Ears” An Arizona-based medical device start-up SafKan Inc is pursuing an alternative to the current standard-of-care for excess or impacted earwax— unchallenged for nearly two centuries—with the world’s first automated ear cleaning device for clinical use, the OtoSet. In this interview, co-founder and CEO Sahil Diwan talks about his experiences in co-founding the company and what’s next for SafKan.

'In MedTech History' - Heart Valve Technology

'In MedTech History' - Heart Valve Technology

In the early 50s, American surgeon Charles Hufnagel, MD began saving lives with a first-of-its-kind plastic aortic assist valve. Today, thanks to this pioneering work, transcatheter aortic valve implantation (TAVI) is firmly established as a safe and effective procedure for treating symptomatic patients with severe aortic stenosis. And, the transcatheter mitral valve repair (TMVR) space is advancing quickly.